Literature DB >> 17218016

IL-18 deficiency inhibits both Th1 and Th2 cytokine production but not the clinical symptoms in experimental autoimmune neuritis.

Rui-Sheng Duan1, Xing-Mei Zhang, Eilhard Mix, Hernan Concha Quezada, Abdu Adem, Jie Zhu.   

Abstract

IL-18 deficient (IL-18-/-) mice were used to investigate the role of IL-18 in the pathogenesis of experimental autoimmune neuritis (EAN) which was induced by immunization of the mice with P0 protein peptide 180-199. The clinical course was not different between IL-18-/- and wild-type mice. The splenic mononuclear cell (MNC) proliferation was also similar in both animal groups. However, the percentages of IFN-gamma, IL-10 and IL-12 positive cells were decreased among infiltrating MNC of cauda equine in IL-18-/- mice. This indicates that IL-18 deficiency inhibits the production of both Th1 and Th2 cytokines in the target organ of mice with EAN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218016     DOI: 10.1016/j.jneuroim.2006.12.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

2.  Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type.

Authors:  Donghui Shen; Fengna Chu; Yue Lang; Chao Zheng; Chunrong Li; Kangding Liu; Jie Zhu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732

3.  NLRC4 Gene Single Nucleotide Polymorphisms Are Associated with the Prognosis of Hemophagocytic Lymphohistiocytosis.

Authors:  Yan Li; Chengdong Sun; Liying Cui; Qiuying Wang
Journal:  Comput Math Methods Med       Date:  2021-12-10       Impact factor: 2.238

Review 4.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.